Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Aprea Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 40 | 1 | 34 | −5 |
| Shares | 2.42M | 49.1K | 2.03M | −335.8K (−14.2%) |
| Value | $4.50M | $91.0K | $1.52M | −$2.89M (−65.5%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Aprea Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 71,959 | $54.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 20,000 | $15.0K | 0.00% |
| StoneX Group Inc. | 14,700 | $11.0K | 0.00% |
| Millennium Management LLC | 10,255 | $8.00K | 0.00% |
Sold out (9)
Institutions that held Aprea Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Kennedy Capital Management, Inc. | 334,796 | $623.0K |
| PDT Partners, LLC | 29,447 | $55.0K |
| Goldman Sachs Group Inc | 29,109 | $54.0K |
| Cubist Systematic Strategies, LLC | 20,572 | $38.0K |
| Gyon Technologies Capital Management, LP | 20,570 | $38.0K |
| Magnus Financial Group LLC | 14,856 | $28.0K |
| Royal Bank of Canada | 11,700 | $22.0K |
| Simplex Trading, LLC | 1,773 | $3.00K |
| Citigroup Inc | 500 | $1.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Aprea Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 49,100 | $91.0K |